Tsoutsou Pelagia G, Eberhardt Anna-Lena, Gruber Günther, Henke Guido, Jeannerret-Sozzi Wendy, Linsenmeier Claudia, Lössl Kristina, Valli Maria-Carla, Weber Walter P, Zaugg Kathrin, Zaman Khalil, Zwahlen Daniel
Radiation Oncology Department, Geneva University Hospitals (HUG) and Faculty of Medicine, University of Geneva (UNIGE), Avenue de la Roseraie 53, 1205, Geneva, Switzerland.
SASRO, .
Strahlenther Onkol. 2025 Feb;201(2):93-105. doi: 10.1007/s00066-024-02332-5. Epub 2024 Dec 6.
Breast cancer (BC) is the most prevalent cancer in women and radiotherapy (RT) is an integral part of its treatment. High-level evidence guides clinical decisions, but given the abundance of guidelines, a need to navigate within the evidence has been identified by the board of the Scientific Association of Swiss Radiation Oncology (SASRO). A pilot project was initiated aiming to create an overview of recent clinically relevant evidence for BC RT, to make it easily available to (radiation) oncologists and radiation oncologists in training.
A panel of 10 radiation oncology experts for BC RT, one expert in BC surgery, and one expert in BC medical oncology critically reviewed the relevant literature. The panel comprehensively represented different geographical regions of Switzerland as well as university, cantonal, and private institutions. We sought to create a consensual overview of the most relevant questions in BC RT today, accompanied by the most recent and relevant available evidence.
From January 2023 to January 2024, the panel met four times to review and work on an initial draft. The final draft was reviewed and accepted by all panelists. We hereby publish this work to make it available to international audiences. After publication, the work will be made available to all SASRO members on the SASRO website. This work is to be updated every 2 years.
The identified need was addressed with a successful pilot project and will be further expanded upon in other tumor pathologies.
乳腺癌是女性中最常见的癌症，放射治疗是其治疗的重要组成部分。高级别证据指导临床决策，但鉴于指南众多，瑞士放射肿瘤学科学协会（SASRO）董事会已确定需要在这些证据中进行梳理。启动了一个试点项目，旨在概述近期乳腺癌放射治疗的临床相关证据，以便（放射）肿瘤学家和接受培训的放射肿瘤学家能够轻松获取。
由10名乳腺癌放射治疗肿瘤学专家、1名乳腺癌外科专家和1名乳腺癌医学肿瘤学专家组成的小组对相关文献进行了严格审查。该小组全面代表了瑞士的不同地理区域以及大学、州立和私立机构。我们试图就当今乳腺癌放射治疗中最相关的问题达成共识性概述，并附上最新和相关的现有证据。
从2023年1月到2024年1月，该小组召开了四次会议来审查和处理初稿。最终稿得到了所有小组成员的审查和认可。我们特此发表这项工作，以便国际读者能够获取。发表后，这项工作将在SASRO网站上提供给所有SASRO成员。这项工作将每两年更新一次。
通过一个成功的试点项目满足了已确定的需求，并将在其他肿瘤病理中进一步扩展。
